Minnesota 2025-2026 Regular Session

Minnesota House Bill HF2906

Introduced
3/27/25  
Refer
3/27/25  

Caption

Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.

Companion Bills

MN SF3971

Similar To Psilocybin therapeutic use program establishment

Previously Filed As

MN HF4577

Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.

MN SF3971

Psilocybin therapeutic use program establishment

MN SF4485

Psilocybin therapeutic use program establishment

MN HF2699

Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated.

MN HF4892

Uncompensated care relief programs established, rulemaking authorized, and money appropriated.

MN HF2847

Clean transportation standard provided, statewide goals and annual standards established, fees authorized, civil enforcement authority provided, penalties established, implementation directed, rulemaking authorized, data practices provided, and money appropriated.

MN HF4085

Biofuel sales volume incentive program established, rulemaking authorized, and money appropriated.

MN HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

MN HF3858

Minnesota Digital Choice Act established, civil penalties established, and administrative rulemaking authorized.

MN HF1750

Minnesota Civic Fund program established, political contribution refund program repealed, rulemaking authorized, and money appropriated.

Similar Bills

NH HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

NJ S3148

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NH HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NM SB219

Medical Psilocybin Act

MA H4050

To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof